Australia is the third largest region by revenue contribution, supported by strong sales teams promoting a diversified portfolio of prescription, OTC and consumer health products. Aspen’s production facilities are also one of the largest manufacturing sites in Australia, with an ability to produce tablets, liquids and semi-solids.
- The Australian pharmaceutical sector was valued at USD13,2 billion as at MAT
- Aspen was ranked fourth by volume in the Australian pharmaceutical sector
for the period ended 31 August 2020, and first among non-generic suppliers.
- Aspen’s overall sales representation performance rankings MAT June 2020 shows
continued improvement and a sustained number one position.
Source: IQVIA – August 2020
Number of products launched:
Average staff turnover*:
Number of product recalls:
Number of work-related fatalities:
* Rate excludes employees transferred in Nutritionals disposal.
|Number of permanent employees|